The Novo Nordisk Foundation has awareded up to 180 M DKK for a 5-year continuation of ODIN with more and new partners from Denmark and abroad.
The continuation of ODIN deserves a new website, which have just been launched. Visit it at www.open-odin.dk
And while we are at it:
Go to the new website to sign up for the ODIN kick-off conference on 27 May 2024 (at the Scandic Falconer in Copenhagen).
ODIN is a collaboration platform where industry and academia co-create open research projects relevant for drug discovery.
Together with a range of Danish and interantional companies within pharma and biotech, the platform was established by five universities:
ODIN is a collaboration platform where industry and academia co-create open research projects relevant for drug discovery.
Together with a range of Danish and interantional companies within pharma and biotech, the platform was established by five universities:
By the end of 2022, the miterm evaluation of the ODIN pilot project (2020-2023) was published.
You can read the full evaluation via the link below. Before you dive in, we can give you a very brief summary: